Long-term follow-up of IDE patients for publication
This device (Hedrocel AVN Intervention Implant) was approved via 510(k) on April 15, 2005. One site was left open to follow patients to 5 year follow-up for publication of device survivorship.
Study Type
OBSERVATIONAL
Enrollment
35
Emory Orthopedic Clinic
Atlanta, Georgia, United States
Safety, Efficacy and longevity of device with patient as opposed to conventional total hip replacement
Time frame: 5 Year Follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.